Page 3 - Edward Barger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ -- The Philadelphia Chapter of NIRI: The Association for Investor Relations announced that its members have elected the following individuals to...

Collaboration expands and underscores commitment to biosimilars portfolio and focus on women’s health with biosimilar candidates for osteoporosis and breast cancerJERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global women’s health company with deep expertise in biosimilar commercialization, today announ...

Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Forendo Pharma, a clinical-stage drug development company focused on novel treatments in women’s health. Forendo’s lead candidate, FOR-6219, is an investigational, potentially first-in-class oral 17ß-hydroxysteroid dehydrogenase type 1 (HSD17B1) inhibitor entering Phase 2 clinical development for endometriosis.

Organon (NYSE: OGN), today celebrates its launch as a global women’s health company with employees and women from around the world, as the Organon executive leadership team rings the opening bell at the New York Stock Exchange (NYSE).

ADDING MULTIMEDIA Organon Launches as New Global Women’s Health Company Only company of its size focused on women’s health Launching with a commitment to listen to women to understand her health needs and help identify solutions that are urgently needed JERSEY CITY, N.J.--(BUSINESS WIRE)--#Health--Organon (NYSE: OGN), today celebrates its launch as a global women’s health company with employees and women from around the world, as the Organon executive leadership team rings the opening bell at the New York Stock Exchange (NYSE). Recognizing the need to listen to a...